252
Views
0
CrossRef citations to date
0
Altmetric
Report

Building Psychedelic Studies as an Interdisciplinary Academic Field: Its Urgency and Its Challenges

ORCID Icon, ORCID Icon, ORCID Icon, &

References

  • Aday, J., Mitzkovitz, C., Bloesch, E., Davoli, C., & Davis, A. (2020). Long-term effects of psychedelic drugs: A systematic review. Neuroscience & Biobehavioral Reviews, 113, 179–189. https://doi.org/10.1016/j.neubiorev.2020.03.017
  • Belouin, S. J., & Henningfield, J. E. (2018). Psychedelics: Where we are now, why we got here, what we must do. Neuropharmacology, 142, 7–19. https://doi.org/10.1016/j.neuropharm.2018.02.018
  • Canadian Institutes of Health Research. (2020, July 8). Surpassing symptomatology: Exploring posttraumatic growth in MDMA-Facilitated cognitive behavioral conjoint therapy for posttraumatic stress disorder. https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=439800&lang=en
  • Carlin, S. (2020). MDMA therapy training for communities of color. MAPS Bulletin Spring, 30(2), 12–18.
  • Cision. (2021, July 21). Small pharma establishes psychedelic-assisted therapy training program. Canada Newswire. https://www.newswire.ca/news-releases/small-pharma-establishes-psychedelic-assisted-therapy-training-program-800181447.html
  • Corrigan, K., Haran, M., McCandliss, C., McManus, R., Cleary, S., Trant, R., Kelly, Y., Ledden, K., Rush, G., O’Keane, V., & Kelly, J. R. (2021). Psychedelic perceptions: Mental health service user attitudes to psilocybin therapy. Irish Journal of Medical Science, 191(3), 1385–1397. https://doi.org/10.1007/s11845-021-02668-2
  • Curtis, E., Jones, R., Tipene Leach, D., Walker, C., Loring, B., Paine, S.-J., & Reid, P. (2019). Why cultural safety rather than cultural competency is required to achieve health equity: A literature review and recommended definition. International Journal for Equity in Health, 18(1), 174. https://doi.org/10.1186/s12939-019-1082-3
  • Davis, A. K., Agin-Liebes, G., España, M., Pilecki, B., & Luoma, J. (2021). Attitudes and beliefs about the therapeutic use of psychedelic drugs among psychologists in the United States. Journal of Psychoactive Drugs, 54(4), 309–318. https://doi.org/10.1080/02791072.2021.1971343
  • DiAngelo, R. (2011). White Fragility. International Journal of Critical Pedagogy, 3(3), 54–70.
  • DiAngelo, R. J. (2018). White fragility: Why it's so hard for White people to talk about racism. Beacon Press.
  • Dubus, Z. (2020). Using psychedelics to “cure” gay adolescents? Conversion therapy trial, France, 1960. Annales médico psychologiques, 178(6), 650–656. https://doi.org/10.1016/j.amp.2020.04.009
  • Dupuis, D. (2021). The socialization of hallucinations: Cultural priors, social interactions, and contextual factors in the use of psychedelics. Transcultural Psychiatry, 59(5), 625–637. https://doi.org/10.1177/13634615211036388
  • Ens, A. (2021). Silencing indigenous pasts: Critical indigenous theory and the history of psychedelics. International Journal of Qualitative Studies in Education, 34(10), 904–914. https://doi.org/10.1080/09518398.2021.1942297
  • Fotiou, E. (2020). The role of indigenous knowledges in psychedelic sciences. Journal of Psychedelic Studies, 4(1), 16–23. https://doi.org/10.1556/2054.2019.031
  • George, J. R., Michaels, T. I., Sevelius, J., & Williams, M. T. (2020). The psychedelic renaissance and the limitations of a White-dominant medical framework: A call for indigenous and ethnic minority inclusion. Journal of Psychedelic Studies, 4(1), 4–15. https://doi.org/10.1556/2054.2019.015
  • Goldsmith, N. (2010). Psychedelic healing: The promise of entheogens for psychotherapy and spiritual development. Healing Arts Press.
  • Griffiths, R. R., Hurwitz, E. S., Davis, A. K., Johnson, M. W., & Jesse, R. (2019). Survey of subjective ‘God encounter experiences’: Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. PLos One, 14(4), e0214377. https://doi.org/10.1371/journal.pone.0214377
  • Grob, C. S., & Bravo, G. (2019). Psychedelics and psychiatry: A new treatment model for the 21st century. In M. Winkelman & B. Sessa (Eds.), Advances in psychedelic medicine: State-of-the-art therapeutic applications (pp. 13–37). Praeger/ABC-CLIO.
  • Hall, W. (2021, September 18). Psychedelic therapy abuse: My experience with Aharon Grossbard, Francoise Bourzat … and their lawyers. Medium. https://medium.com/@willhall/psychedelic-therapy-abuse-my-experience-with-aharon-grossbard-francoise-bourzat-and-their-a1f0f6d06d64
  • Hall, W., Stjepanović, D., Caulkins, J., Lynskey, M., Leung, J., Campbell, G., & Degenhardt, L. (2019). Public health implications of legalising the production and sale of cannabis for medicinal and recreational use. The Lancet, 394(10208), 1580–1590. https://doi.org/10.1016/S0140-6736(19)31789-1
  • Klein, J. T. (1990). Interdisciplinarity : History, theory, and practice. Wayne State University Press.
  • Lafrance, A., Strahan, E., Bird, B. M., St. Pierre, M., & Walsh, Z. (2021). Classic psychedelic use and mechanisms of mental health: Exploring the mediating roles of spirituality and emotion processing on symptoms of anxiety, depressed mood, and disordered eating in a community sample. Journal of Humanistic Psychology, 1-19. https://doi.org/10.1177/00221678211048049. 002216782110480.
  • Lekhtman, A. (2019, August 23). The first-ever MDMA therapy training for communities of color was vital. Filter. https://filtermag.org/mdma-therapy-people-color/
  • Luse, B. (2019, February 4). Blue Pill. The Nod. Gimlet Media.
  • Lutkajtis, A. (2020). Lost saints: Desacralization, spiritual abuse and magic mushrooms. Fieldwork in Religion, 14(2), 118–139. https://doi.org/10.1558/firn.40554
  • Marks, M., & Cohen, I. G. (2021). Psychedelic therapy: A roadmap for wider acceptance and utilization. Nature Medicine, 27(10), 1669–1671. https://doi.org/10.1038/s41591-021-01530-3
  • Neitzke-Spruill, L., & Glasser, C. (2018). A gratuitous grace: The influence of religious set and intent on the psychedelic experience. Journal of Psychoactive Drugs, 50(4), 314–321. https://doi.org/10.1080/02791072.2018.1494869
  • Page, L. A., Rehman, A., Syed, H., Forcer, K., & Campbell, G. (2021). The readiness of psychiatrists to implement psychedelic-assisted psychotherapy. Frontiers in Psychiatry, 12, 12. https://doi.org/10.3389/fpsyt.2021.743599
  • Parker, J. S., Murray, K., Boegel, R., Slough, M., Purvis, L., & Geiling, C. (2021). An exploratory study of school psychology students’ perceptions of religious and spiritual diversity training in their graduate programs. Contemporary School Psychology, 27(2), 1–16. https://doi.org/10.1007/s40688-021-00396-z
  • Phelps, J. (2017). Developing guidelines and competencies for the training of psychedelic therapists. Journal of Humanistic Psychology, 57(5), 450–487. https://doi.org/10.1177/0022167817711304
  • Pittaway, D. A. (2018). “To learn healing knowledge”: Philosophy, psychedelic studies and transformation. South African Journal of Philosophy, 37(4), 438–451. https://doi.org/10.1080/02580136.2018.1532186
  • Plant, E. A., & Devine, P. G. (2003). The antecedents and implications of interracial anxiety. Personality & Social Psychology Bulletin, 29(6), 790–801. https://doi.org/10.1177/0146167203029006011
  • Pollan, M. (2018). How to change your mind: What the new science of psychedelics teaches us about consciousness, dying, addiction, depression, and transcendence. Penguin Press.
  • Potter, A., & Weinstock, D. (2019). High time: The legalization and regulation of cannabis in Canada. McGill-Queen’s University Press.
  • Proactive. (2020, October 5). Mind Medicine to commit $5M to launch and develop clinical training program in field of psychedelic therapies and medicine. https://ca.proactiveinvestors.com/companies/news/930665/mind-medicine-to-commit-5m-to-launch-and-develop-clinical-training-program-in-field-of-psychedelic-therapies-and-medicine-930665.html
  • Raphael, D. (Ed.). (2016). Social determinants of health : Canadian perspectives (3rd ed.). Press Inc.
  • Richards, W. (2016). Sacred Knowledge: Psychedelics and religious experience. Colombia University Press.
  • Rochester, J., Vallely, A., Grof, P., Williams, M. T., Chang, H., & Caldwell, K. (2021). Entheogens and psychedelics in Canada: Proposal for a new paradigm. Canadian Psychology/Psychologie Canadienne, 63(3), 413–430. Advance online publication. https://doi.org/10.1037/cap0000285
  • Rubin, R. (2019). Philanthropists fund Johns Hopkins center for study of psychedelics. JAMA: The Journal of the American Medical Association, 322(19), 1849–1851. https://doi.org/10.1001/jama.2019.17126
  • Sessa, B. (2014). Why psychiatry needs psychedelics and psychedelics need psychiatry. Journal of Psychoactive Drugs, 46(1), 57–62. https://doi.org/10.1080/02791072.2014.877322
  • Sloshower, J. (2018). Integrating psychedelic medicines and psychiatry: Theory and methods of a model clinic. In B. C. Labate & C. Cavnar (Eds.), Plant medicines, healing and psychedelic science cultural perspectives (pp. 113–132). Springer International Publishing. https://doi.org/10.1007/978-3-319-76720-8
  • Smith, W. R., & Appelbaum, P. S. (2021). Two models of legalization of psychedelic substances: Reasons for concern. JAMA: The Journal of the American Medical Association, 326(8), 697–698. https://doi.org/10.1001/jama.2021.12481
  • Smith, D., Faber, S., Buchanan, N. T., Foster, D., & Green, L. (in press). The need for psychedelic-assisted therapy in the black community and the burdens of its provision. Frontiers. https://www.frontiersin.org/articles/10.3389/fpsyt.2021.774736/abstract
  • Strauss, D., de la Salle, S., Sloshower, J., & Williams, M. T. (2021). Research abuses against people of colour and other vulnerable groups in early psychedelic research. Journal of Medical Ethics, 48(10), 728–737. https://doi.org/10.1136/medethics-2021-107262
  • Tai, S. J., Nielson, E. M., Lennard-Jones, M., Johanna Ajantaival, R. L., Winzer, R., Richards, W. A., Reinholdt, F., Richards, B. D., Gasser, P., & Malievskaia, E. (2021). Development and evaluation of a therapist training program for psilocybin therapy for treatment-resistant depression in clinical research. Frontiers in Psychiatry, 12, 586682. https://doi.org/10.3389/fpsyt.2021.586682
  • United Kingdom Research and Innovation. (2021, December 14). Psilocybin as a treatment for major depression. https://gtr.ukri.org/projects?ref=MR%2FJ00460X%2F1
  • University of Ottawa. (2021, September 2). Canada’s first microprogram on psychedelic studies is now being offered online at the faculty of arts at the University of Ottawa. https://arts.uottawa.ca/en/news/canadas-first-microprogram-psychedelic-studies-now-being-offered-online-faculty-arts-university
  • Vieten, C., & Lukoff, D. (2021). Spiritual and religious competencies in psychology. The American Psychologist, 77(1), 26–38. https://doi.org/10.1037/amp0000821
  • Williams, M. T., Kanter, J. W., Peña, A., Ching, T. H. W., & Oshin, L. (2020). Reducing microaggressions and promoting interracial connection: The racial harmony workshop. Journal of Contextual and Behavioral Science, 16, 153–161. https://doi.org/10.1016/j.jcbs.2020.04.008
  • Williams, M. T., Reed, S., & George, J. (2021). Culture and psychedelic psychotherapy: Ethnic and racial themes from three Black women therapists. Journal of Psychedelic Studies, 4(3), 125–138. https://doi.org/10.1556/2054.2020.00137

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.